105 related articles for article (PubMed ID: 6281754)
1. Immunohistochemical demonstration of placental protein 5 in trophoblastic tumours.
Lee JN; Wahlström T; Seppälä M; Salem HT; Ouyang PC; Chard T
Placenta; 1982; 3(1):67-70. PubMed ID: 6281754
[TBL] [Abstract][Full Text] [Related]
2. Placental protein 5 in gestational trophoblastic disease: localization and circulating levels.
Nisbet AD; Bremner RD; Horne CH; Brooker D; Twiggs LB; Okagaki T
Am J Obstet Gynecol; 1982 Oct; 144(4):396-401. PubMed ID: 6289667
[TBL] [Abstract][Full Text] [Related]
3. Placenta-associated plasma protein-A (PAPP-A, SP4) in trophoblastic tumours.
Wahlström T; Teisner B; Lee JN; Grudzinskas JG; Seppälä M; Folkersen J
Acta Pathol Microbiol Scand A; 1981 Jan; 89(1):65-6. PubMed ID: 6164245
[TBL] [Abstract][Full Text] [Related]
4. [Pregnancy and placental proteins (SP1, HCG, PP5, alpha 2-PAG) in trophoblastic tumor diseases].
Than G; Csaba I; Szabó D; Karg N; Göcze P
Orv Hetil; 1981 Oct; 122(43):2650-4. PubMed ID: 6275329
[No Abstract] [Full Text] [Related]
5. Detection of pregnancy specific beta1-glycoprotein in formalin-fixed tissues.
Horne CH; Towler CM; Milne GD
J Clin Pathol; 1977 Jan; 30(1):19-23. PubMed ID: 190273
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of placental protein 19, human chorionic gonadotrophin and pregnancy-specific beta 1-glycoprotein as immunohistochemical markers for extravillous trophoblast in pregnancy and trophoblastic disease.
Takayama M; Isaka K; Suzuki Y; Funayama H; Suzuki Y; Akiya K; Bohn H
Histochemistry; 1989; 93(2):167-73. PubMed ID: 2559069
[TBL] [Abstract][Full Text] [Related]
7. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
[TBL] [Abstract][Full Text] [Related]
8. Immunologic and biological properties and clinical significance of placental proteins PP5 and PP12.
Seppälä M; Rutanen EM; Siiteri JE; Wahlström T; Koistinen R; Pietilä R; Bohn H
Ann N Y Acad Sci; 1983; 417():368-82. PubMed ID: 6322659
[TBL] [Abstract][Full Text] [Related]
9. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast.
Seppälä M; Wahlström T; Bohn H
Int J Cancer; 1979 Jul; 24(1):6-10. PubMed ID: 225283
[No Abstract] [Full Text] [Related]
11. [An immunohistochemical study in conjunction with the enzyme labelled antibody method to discern the relevancy between the localization of hCG, hPL and the functions of the normal and malignant trophoblast (author's transl)].
Tanaka A
Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):579-88. PubMed ID: 6282995
[No Abstract] [Full Text] [Related]
12. Nuclear DNA content of trophoblastic tumors.
Sugimori H; Kashimura Y; Kashimura M; Taki I
Acta Cytol; 1978; 22(6):542-5. PubMed ID: 216204
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evidence for prolactin in trophoblastic tumors.
Lee JN; Wahlström T; Ouyang PC; Chen TY; Seppälä M
Gynecol Oncol; 1981 Jun; 11(3):299-303. PubMed ID: 6265327
[No Abstract] [Full Text] [Related]
14. Prognostic significance of the new placental proteins in trophoblastic disease.
Tsakok FH; Koh S; Chua SE; Ratnam SS; Teisner B; Jones GR; Sinosich M; Grudzinskas JG
Br J Obstet Gynaecol; 1983 May; 90(5):483-6. PubMed ID: 6189512
[TBL] [Abstract][Full Text] [Related]
15. Beta lactoglobulin homologue placental protein 14 (PP14) in serum of patients with trophoblastic disease and non-trophoblastic gynecologic malignancy.
Than GN; Tatra G; Szabó DG; Csaba IF; Bohn H
Arch Gynecol Obstet; 1988; 243(3):131-7. PubMed ID: 2844125
[TBL] [Abstract][Full Text] [Related]
16. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of relaxin in gynecologic tumors.
Yki-Järvinen H; Wahlström T; Seppälä M
Cancer; 1983 Dec; 52(11):2077-80. PubMed ID: 6313179
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-"specific" beta 1-glycoprotein (SP1): purification, characterization, quantification and clinical application in malignancies (a review).
Sørensen S
Tumour Biol; 1984; 5(6):275-302. PubMed ID: 6100221
[No Abstract] [Full Text] [Related]
19. [Beta subunit of chorionic gonadotropin in the control of benign trophoblastic disease].
Vargas López E; Cano Vargas CE; Vázquez Matute LH; Aldana Bustamante A; Santini Villar AJ
Ginecol Obstet Mex; 1982 Jan; 50(297):4-7. PubMed ID: 6292056
[No Abstract] [Full Text] [Related]
20. Possible new markers in trophoblastic diseases.
Inaba N; Ishige H; Ijichi M; Satoh N; Katoh T; Sekiya S; Shirotake S; Ohkawa R; Takamizawa H; Nitoh A; Renk T; Bohn H
Am J Obstet Gynecol; 1982 Aug; 143(8):973-4. PubMed ID: 6980595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
